Pittsburgh's Mylan Inc. (NASDAQ: MYL) has completed its acquisition of Bioniche Pharma Holdings Ltd. sooner than expected, launching a North American institutional business that includes the Irish company's injectable drugs.
Generic and specialty drugmaker Milan Inc. (NYSE: MYL) has agreed to buy injectable drug company Bioniche Pharma Holdings Ltd. for $550 million in cash, gaining the Pittsburgh, Pennsylvania’s Milan entrance to the North American injectables market. Bioniche Pharma is a global specialty sterile injectable pharmaceutical company based in Galway, Ireland with a majority of its […]
Zelis highlights how employers, payers, and consumers are integrating digital tools to manage healthcare costs.